<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="used in cardiology [2]. The European Consensus of 2015 defines" exact="propranolol" post="as the first line therapy for IHs, especially during"/>
 <result pre="tolerability, reserving a secondary or obsolete role to steroids, interferon," exact="vincristine" post="and surgery. The therapeutic dose ranges from 2 mg/kg/day"/>
 <result pre="clinical experience of the least 10 years demonstrate that oral" exact="propranolol" post="is successfully used in the treatment of IHs. Recent"/>
 <result pre="of IHs. Recent scientific literature proves that the use of" exact="propranolol" post="during the first months of life do not compromise"/>
 <result pre="Oranges, M. Cutrone, P. Dalmonte. Safety and effectiveness of oral" exact="propranolol" post="for infantile hemangiomas started before 5 weeks and after"/>
 <result pre="Torrelo A. Study of cognitive function in children treated with" exact="propranolol" post="for infantile hemangioma. Pediatr Dermatol. 2017; 34:554-558. A22 Depression"/>
 <result pre="RAD positive cases or score 5 children using 50 mg." exact="amoxicillin" post="in two daily doses for 6 days [3]. Other"/>
 <result pre="(0-14 years old) and an increase in the ratio of" exact="amoxicillin" post="to amoxicillin-clavulanate acid prescriptions (i.e. ratio of first choice"/>
 <result pre="Temporal trend in total antibiotic prescription rate and ratio of" exact="amoxicillin" post="to amoxicillin-clavulanic acid in children, 2005-2017 A37 Elaborating the"/>
 <result pre="2017, the fixed-dose combination of sofosbuvir/ledipasvir and the combination of" exact="sofosbuvir" post="with ribavirin have been approved by the European Medicines"/>
 <result pre="fixed-dose combination of sofosbuvir/ledipasvir and the combination of sofosbuvir with" exact="ribavirin" post="have been approved by the European Medicines Agency for"/>
 <result pre="children are available for sofosbuvir/ledipasvir in children aged 6-17, for" exact="sofosbuvir" post="and ribavirin for children older than 12 years, for"/>
 <result pre="available for sofosbuvir/ledipasvir in children aged 6-17, for sofosbuvir and" exact="ribavirin" post="for children older than 12 years, for the combination"/>
 <result pre="combination of ombitasvir/paritaprevir/ritonavir with or without dasabuvir, with or without" exact="ribavirin" post="for children older than 12 years with hepatitis C"/>
 <result pre="genotype 1 or 4 infection, and for the combination of" exact="sofosbuvir" post="with daclatasvir for children with hepatitis C virus genotype"/>
 <result pre="or 4 infection, and for the combination of sofosbuvir with" exact="daclatasvir" post="for children with hepatitis C virus genotype 4 infection"/>
 <result pre="Resti M. Kinetic of virologic response to pegylated interferon and" exact="ribavirin" post="in children with chronic hepatitis C predicts the effect"/>
 <result pre="prevent late-onset sepsis by any agent in preterm neonates, whereas" exact="fluconazole" post="and (to a lesser extent) nystatin can prevent invasive"/>
 <result pre="in preterm neonates, whereas fluconazole and (to a lesser extent)" exact="nystatin" post="can prevent invasive systemic fungal infections. Finally, specific measures"/>
 <result pre="with deficiency of selected micronutrients such as vitamin A, and" exact="folic acid." post="Historically, celiac disease has been associated with many micronutrient"/>
 <result pre="opinion recommends checking for vitamin D, vitamin A, zinc, copper," exact="folic acid," post="and ferritin [10]. Routine measuring of fat-soluble vitamins levels"/>
 <result pre="patientâ€™s medical history, to test anti-thyroid antibodies (anti-tireoperoxidase and anti-" exact="thyroglobulin" post="antibodies) and to do a thyroid ultrasound. We have"/>
</results>
